BioNovix information, bionovix research, bionovix business details

BioNovix Management:
Mark Labertew, CEO
Fred Auzenne, Director
Eric H. Kuhrts, Chairman and Chief Science Officer

BioNovix Information: BioNovix has a prelaunch event scheduled for January 12-14, 2007. BioNovix IBC's market MeridiumXN, a proprietary formulation of xanthohumol. According to the BioNovix site " wealth of established research shows that xanthohumol acts as a potent wellness agent in the body and plays an active role in counteracting a wide range of conditions associated with chronic health problems. MeridiumXN is the first and only health product that makes xanthohumol available in a form you can metabolize."

Update as of 8/12/2008: Cory Carter of Bionovix has advised us of recent management changes at Bionovix. Mark Labertew is the new CEO, Fred Auzenne is now a Director, and changes to the bio for Eric H. Kuhrts have been posted to our archive.

Update as of 5/1/2009: BioNovix has closed.

Find A Rep for BioNovix

Check this company's virtual trading value on NprosMarket.com

Search for Info on these Executives